Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Growth by 2028

Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Organization Size (Small and Medium Organizations and Large Organizations), Offerings (Products, Platforms, and Services), Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, and Others), Clinical Indication (Cardiovascular Diseases, Neurodegenerative Diseases, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, and Others)

Report Date : May 2022
Report Code : TIPRE00029238

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 208

The Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is expected to reach US$ 1,870.3 million by 2028 from US$ 816.0 million in 2021; it is estimated to grow at a CAGR of 12.6% from 2021 to 2028.

In-silico clinical trials can supplement phase II drug trials to explore the safety and efficacy in the more infrequent phenotypes that usually appear only in phase III and predict the dose-effect relationship. Computational study in natural drug discovery is used to determine the metabolic pathways of active molecules and find the new targets and new molecules with high affinity to those targets. For instance, camptothecin derivatives (monoterpene-indole alkaloids) have been clinically employed as antitumor drugs. Such studies may explain how an in-silico metabolic analysis can improve the experimental decorations to gain more comprehensible biological information. Another aspect of human trials is that they are expensive, lengthy, and are typically designed with a narrow scope. But in-silico trials can be designed to answer a wide variety of relevant questions by providing sufficient statistical power to test the different hypotheses with a relatively small increase in resources associated with evaluating more models once the computational machinery is developed and implemented.

Furthermore, unlike conventional clinical trials, in-silico clinical trials are readily approved and authorized by the food and drug administration (FDA). Incrementally but inevitably, the in-silico clinical trial approach is expected to become the most significant evidence for regulatory evaluations. These factors indicate that the benefits mentioned above are substantially driving the in-silico trial market in Europe.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market at a promising CAGR during the forecast period.

Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

Inquire for Discount

Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Request discounts available for Start-Ups & Universities

The market for in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into organization size, offerings, application, clinical indication, and end user. Based on organization size, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into small and medium organizations and large organizations. Based on offerings, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into products, platforms, and services. Based on application, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into product design and discovery, product development, pre-clinical targeting, assessment of drugs and other biomedical products, and others. Based on clinical indication, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into cardiovascular diseases, neurodegenerative diseases, oncology, rare diseases, metabolic diseases, immune based diseases, infectious diseases, and others. Based on end user, the in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into pharmaceutical and biopharmaceutical companies, medical technology companies, contract research organizations, and others. By country, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into Germany, the UK, France, Spain, Italy, and the rest of Europe.

InSilicoTrials Technologies; Feops; CADFEM Medical GmbH; Dassault Systèmes SE; Virtonomy GmbH; Certara Inc.; Computational Life; NOVA; TwInsight Medical; Ansys, Inc.; Synopsys, Inc.; Sensyne Health plc.; and Cerner Corporation are among the leading companies in the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market.

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

This text is related
to segments covered.

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.2.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Organization Size

1.2.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Offering

1.2.3 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Application

1.2.4 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Clinical Indication

1.2.5 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By End User

1.2.6 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

4.3 Experts Opinion

5. In-Silico Trial Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Concerns Over Animal Welfare and Benefits

5.1.2 Insufficient Variable Patient Data and Limited Timescale

5.2 Market Restraints

5.2.1 Insufficient Variable Patient Data and Limited Timescale

5.3 Market Opportunities

5.3.1 Growing Applications of In-silico Trials in Radiology and Orthopedic Device Industry

5.4 Future Trends

5.4.1 Adoption of Artificial Intelligence in In-Silico Drug Discovery

5.5 Impact Analysis

6. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Europe Analysis

6.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue Forecast and Analysis

7. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028– by Organization Size

7.1 Overview

7.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, By Organization Size, 2020 & 2028 (%)

7.3 Large Organizations

7.3.1 Overview

7.3.2 Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Small and Medium Organizations

7.4.1 Overview

7.4.2 Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

8. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Offering

8.1 Overview

8.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

8.3 Products

8.3.1 Overview

8.3.2 Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

8.4 Platforms

8.4.1 Overview

8.4.2 Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

8.5 Services

8.5.1 Overview

8.5.2 Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Application

9.1 Overview

9.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

9.3 Product Design and Discovery

9.3.1 Overview

9.3.2 Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.4 Product Development

9.4.1 Overview

9.4.2 Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.5 Pre-Clinical Targeting

9.5.1 Overview

9.5.2 Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.6 Assessment of Drugs and Other Biomedical Products

9.6.1 Overview

9.6.2 Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.7 Others (Optimization and Market Access)

9.7.1 Overview

9.7.2 Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Clinical Indication

10.1 Overview

10.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

10.3 Cardiovascular Disease

10.3.1 Overview

10.3.2 Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.4 Neurodegenerative Disease

10.4.1 Overview

10.4.2 Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.5 Oncology

10.5.1 Overview

10.5.2 Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.6 Rare Diseases

10.6.1 Overview

10.6.2 Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.7 Metabolic Diseases

10.7.1 Overview

10.7.2 Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.8 Immune Based Diseases

10.8.1 Overview

10.8.2 Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.9 Infectious Diseases

10.9.1 Overview

10.9.2 Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.10 Others (Haematology, Diabetes, Dermatology)

10.10.1 Overview

10.10.2 Others (Haematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – End User

11.1 Overview

11.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

11.3 Pharmaceutical and Biotechnology Companies

11.3.1 Overview

11.3.2 Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.4 Medical Technology Companies

11.4.1 Overview

11.4.2 Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.5 Contract Research Organizations

11.5.1 Overview

11.5.2 Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.6 Others (Universities and Research Centres)

11.6.1 Overview

11.6.2 Others (Universities and Research Centres): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

12. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 – Geographical Analysis

12.1 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

12.1.1 Overview

12.1.2 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.4 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.4.1 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.4.2 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.4.3 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)

12.1.5.1 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.1 Overview

12.1.5.1.2 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.3 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.4 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.5 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.6 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.7 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.1 Overview

12.1.5.2.2 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.3 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.4 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.5 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.6 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.7 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.1 Overview

12.1.5.3.2 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.3 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.4 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.5 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.6 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.7 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.1 Overview

12.1.5.4.2 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.3 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.4 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.5 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.6 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.7 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.1 Overview

12.1.5.5.2 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.3 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.4 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.5 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.6 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.7 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.1 Overview

12.1.5.6.2 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.3 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.4 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.5 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.6 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.7 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

13. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 InSilicoTrials Technologies

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 FEops

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 CADFEM Medical GmbH

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Dassault Systèmes SE

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Virtonomy GmbH

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Certara Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Computational Life

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Novadiscovery

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 TwInsight Medical

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Ansys, Inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Synopsys, Inc.

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Sensyne Health plc.

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

14.13 Cerner Corporation

14.13.1 Key Facts

14.13.2 Business Description

14.13.3 Products and Services

14.13.4 Financial Overview

14.13.5 SWOT Analysis

14.13.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 2. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 3. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 7. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 8. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 11. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 12. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 13. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 14. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 15. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 17. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 18. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 19. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 20. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 22. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 23. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 26. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 27. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 28. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 34. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 35. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 36. Organic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Table 37. Inorganic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Table 38. Glossary of Terms

LIST OF FIGURES

Figure 1. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Segmentation

Figure 2. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Overview

Figure 3. Large Organizations Segment Held Largest Share of Organization Size Segment in In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, Industry Landscape

Figure 6. Europe: PEST Analysis

Figure 7. Experts Opinion

Figure 8. In-Silico Trial Market: Impact Analysis of Drivers and Restraints

Figure 9. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2020 & 2028 (%)

Figure 11. Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 14. Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15. Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16. Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 18. Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19. Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20. Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21. Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22. Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 24. Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27. Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28. Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29. Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30. Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. Others (Hematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 33. Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34. Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35. Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36. Others (Universities and Research Centers): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Key Country – Revenue (2021) (US$ Million)

Figure 38. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

Figure 39. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)

Figure 40. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)

InSilicoTrials Technologies
Feops
CADFEM Medical GmbH
Dassault Systèmes SE
Virtonomy GmbH
Certara Inc.
Computational Life
NOVA
TwInsight Medical
Ansys, Inc.
Synopsys, Inc.
Sensyne Health plc.
Cerner Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.